BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis
{{output}}
VEGF inhibitors are one of the most successful antiangiogenic drugs in the treatment of many solid tumors. Nevertheless, pancreatic adenocarcinoma (PAAD) cells can reinstate tumor angiogenesis via activation of VEGF-independent pathways, thereby conferring res... ...